Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Sinografin Generic Name & Formulations
Legal Class
Rx
General Description
Diatrizoate meglumine 527mg, iodipamide meglumine 268mg; per mL; soln for intrauterine instillation; contains sodium 0.91mg/mL, organically bound iodine 380mg/mL.
Pharmacological Class
Radiopaque contrast medium.
How Supplied
Single-dose vial (10mL)—10
Manufacturer
Sinografin Indications
Indications
Hysterosalpingography.
Sinografin Dosage and Administration
Adult
See literature for information on administration and radiography. Empty bladder before exam. 3–4mL administered in fractional doses of approx. 1mL are usually adequate to visualize the uterus; an additional 3–4mL will demonstrate the tubes. Total doses of 1.5–10mL have been used.
Children
Not established.
Sinografin Contraindications
Contraindications
Pregnancy. During menstrual period. External genitalia or genital tract infection. Within 30 days of curettage or conization or within 6 months following termination of pregnancy.
Sinografin Boxed Warnings
Not Applicable
Sinografin Warnings/Precautions
Warnings/Precautions
Should be performed by personnel trained in diagnostic procedures that involve radiopaque diagnostic agents. Carcinoma of the uterus and/or uterine/tubes; possible dispersion of carcinogenic cells during procedure. History of asthma/allergy. Nursing mothers.
Sinografin Pharmacokinetics
See Literature
Sinografin Interactions
Interactions
May interfere with thyroid tests.
Sinografin Adverse Reactions
Adverse Reactions
Dizziness, syncope, hypotension, chills, fever, nausea, vomiting, abdominal pain and tenderness, hypersensitivity reactions; rare: bradycardia, hypotension, cardiac arrest, death.
Sinografin Clinical Trials
See Literature
Sinografin Note
Not Applicable
Sinografin Patient Counseling
See Literature
